(Reuters) - VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine from ...
CAMBRIDGE, MASSACHUSETTS and VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct 26, 2015) - VBI Vaccines Inc. (VBIV) ("VBI") and SciVac Therapeutics Inc. (VAC.TO)(SVACF) ("SciVac") announced today that ...
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Jul 25, 2016) - VBI Vaccines Inc. (VBIV)(VBV.TO) ("VBI") is pleased to announce the appointment of Dr. Francisco Diaz-Mitoma, M.D., Ph.D., as Chief Medical ...
With an eye towards someday developing a “functional cure” for hepatitis B, VBI Vaccines is triaging the rest of its programs and sending 30-35% of staff out the door. The company will zero in on ...
Sanofi Pasteur has chosen VBI's LPV™ technology to develop a more stable formulation of a key Sanofi Pasteur vaccine candidate. The collaboration will leverage VBI's LPV™ technology, which allows for ...
A sell-off that began last week continues. High levels of volatility are the norm for small biotech stocks like VBI Vaccines. It's not surprising that shares would fall after the meteoric rise earlier ...
VBI will continue to heavily prioritize making a difference in both prevention and treatment of hepatitis B (HBV) with PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] and immunotherapeutic candidate ...
Data from Phase 1b/2a study in chronic HBV patients show robust HBV specific T cell responses in ≥ 50% of evaluable patients across all study arms of VBI-2601 (BRII-179) VBI-2601 (BRII-179) was ...
The race to bring a COVID-19 vaccine to market is far from over. There are several companies vying for first place, with these names representing Big Pharma as well as the smaller end of the biotech ...
Investors are fired up about an analyst's enthusiastic upgrade of the biotech stock. The main reason why investors are so excited stemmed more from the comments by the analyst than the upgrade itself.
VBI will continue to heavily prioritize making a difference in both prevention and treatment of hepatitis B (HBV) with PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] and immunotherapeutic candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results